(INNS)
SOLITOMAB(INND)
SOLITOMAB(INNC)
IMMUNOGLOBULIN SCFV-SCFV, ANTI-[HOMO SAPIENS EPCAM (EPITHELIAL CELL ADHESION MOLECULE, TUMOR-ASSOCIATED CALCIUM SIGNAL TRANSDUCER 1, TACSTD1, GASTROINTESTINAL TUMOR-ASSOCIATED PROTEIN 2, GA733-2, EPITHELIAL GLYCOPROTEIN 2, EGP-2, KSA, KS1/4 ANTIGEN, M4S1, TUMOR ANTIGEN 17-1A, EP-CAM, EPCAM, CD326)]/ANTI-[HOMO SAPIENS CD3E (CD3 EPSILON)], MUS MUSCULUS MONOCLONAL ANTIBODY BISPECIFIC SINGLE CHAIN; SCFV ANTI-EPCAM [MUS MUSCULUS V-KAPPA (IGKV8-19*01 (98.00%)-IGKJ5*01 L126>I (112)) [12.3.9] (1-113) -15-MER TRIS(TETRAGLYCYL-SERYL) LINKER (114-128) -MUS MUSCULUS VH (IGHV1- 54*01 (85.90%)-(IGHD)-IGHJ4*01, S123>T (243)) [8.8.14] (129- 248)] -5-MER TETRAGLYCYL-SERYL LINKER (249-253) -SCFV ANTI-CD3E [HUMANIZED VH (HOMO SAPIENS IGHV1-46*01 (82.50%)-(IGHD)- IGHJ6*01) [8.8.12] (254-372) -18-MER LINKER (373-390) -V-KAPPA (MUS MUSCULUS IGKV4-59*01 (81.70%)-IGKJ1*01 L124>V (493) [5.3.9] (391-496)] -HEXAHISTIDINE (497-502), RECOMMENDED INN: LIST 68(WHO)
SOLITOMABUM(INN)